GlassScriptPhysician profile
Michael Alexander
NPI 1275001406
$4,364.23
in general payments reported to CMS, 2019-2025
29 companies · $1,390 in 2025
The $1,390 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $87.15 · 2022: $124 · 2023: $334 · 2024: $2,430 · 2025: $1,390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,047 · Travel and Lodging: $1,007 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,047.48 |
| Travel and Lodging | $1,006.87 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,688.67 | 2024 | Axonics, Bulkamid |
| Janssen Biotech, INC. | $472.38 | 2023-2025 | Erleada |
| Teleflex LLC | $423.16 | 2023-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $284.46 | 2025 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $198.44 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $171.84 | 2023-2025 | Gemtesa |
| Antares Pharma, INC. | $141.77 | 2024-2025 | Xyosted |
| Medical Device Business Services, INC. | $123.73 | 2022 | |
| Ethicon US, LLC | $87.15 | 2021 | |
| Tolmar, INC. | $85.33 | 2024-2025 | Eligard |
| Accord Healthcare, INC. | $78.37 | 2025 | |
| Endo USA, INC. | $67.05 | 2024-2025 | Xiaflex, Aveed, Edex |
| Olympus America INC. | $58.18 | 2023-2024 | Itind System |
| Abbvie INC. | $51.37 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $50.49 | 2025 | Adstiladrin |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $47.46 | 2024-2025 | Xt Cdx |
| Novartis Pharmaceuticals Corporation | $43.46 | 2025 | |
| Urogen Pharma, INC. | $39.71 | 2025 | |
| Halozyme INC | $38.87 | 2023-2025 | Hylenex Recombinant |
| Bioprotect Medical, INC. | $26.44 | 2025 | Bioprotect Balloon Implant System |
| Blue Earth Diagnostics | $25.05 | 2025 | Posluma |
| Dendreon Pharmaceuticals LLC | $23.93 | 2025 | Provenge |
| Progenics Pharmaceuticals, INC. | $23.77 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $21.24 | 2024 | Imfinzi |
| Laborie Medical Technologies Corp. | $20.69 | 2025 | |
| Coloplast Corp | $20.17 | 2025 | |
| 180 Medical, INC. | $18.51 | 2024 | Cure Catheter |
| Novo Nordisk INC | $18.12 | 2023 | Rybelsus, Ozempic |
| Astellas Pharma US INC | $14.42 | 2024 | Xtandi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.